101 related articles for article (PubMed ID: 19673074)
21. Neutralization of the neuromuscular inhibition of venom and taipoxin from the taipan (Oxyuranus scutellatus) by F(ab')2 and whole IgG antivenoms.
Herrera M; de Cássia de O Collaço R; Villalta M; Segura Á; Vargas M; Wright CE; Paiva OK; Matainaho T; Jensen SD; León G; Williams DJ; Rodrigues-Simioni L; Gutiérrez JM
Toxicol Lett; 2016 Jan; 241():175-83. PubMed ID: 26621539
[TBL] [Abstract][Full Text] [Related]
22. Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography.
Raweerith R; Ratanabanangkoon K
J Immunol Methods; 2003 Nov; 282(1-2):63-72. PubMed ID: 14604541
[TBL] [Abstract][Full Text] [Related]
23. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production.
Rojas G; Jiménez JM; Gutiérrez JM
Toxicon; 1994 Mar; 32(3):351-63. PubMed ID: 8016856
[TBL] [Abstract][Full Text] [Related]
24. Purification of equine whole IgG snake antivenom by using an aqueous two phase system as a primary purification step.
Vargas M; Segura Á; Villalta M; Herrera M; Gutiérrez JM; León G
Biologicals; 2015 Jan; 43(1):37-46. PubMed ID: 25458474
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the viral safety of antivenoms fractionated from equine plasma.
Burnouf T; Griffiths E; Padilla A; Seddik S; Stephano MA; Gutiérrez JM
Biologicals; 2004 Sep; 32(3):115-28. PubMed ID: 15536042
[TBL] [Abstract][Full Text] [Related]
26. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
27. Effect of storage temperature on the stability of the liquid polyvalent antivenom produced in Costa Rica.
Rojas G; Espinoza M; Lomonte B; Gutiérrez JM
Toxicon; 1990; 28(1):101-5. PubMed ID: 2330601
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a reverse phase HPLC method for the determination of caprylic acid in formulations of therapeutic immunoglobulins and its application to antivenom production.
Herrera M; Meneses F; Gutiérrez JM; León G
Biologicals; 2009 Aug; 37(4):230-4. PubMed ID: 19375941
[TBL] [Abstract][Full Text] [Related]
29. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
[TBL] [Abstract][Full Text] [Related]
30. Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?
Mateljak Lukačević S; Kurtović T; Borić J; Halassy B
Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878221
[TBL] [Abstract][Full Text] [Related]
31. Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays.
de Roodt AR; Clement H; Dolab JA; Litwin S; Hajos SE; Boyer L; Alagón A
Clin Toxicol (Phila); 2014 Jul; 52(6):594-603. PubMed ID: 24940642
[TBL] [Abstract][Full Text] [Related]
32. A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance.
Parkkinen J; Rahola A; von Bonsdorff L; Tölö H; Törmä E
Vox Sang; 2006 Feb; 90(2):97-104. PubMed ID: 16430667
[TBL] [Abstract][Full Text] [Related]
33. Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches.
Mateljak Lukačević S; Kurtović T; Lang Balija M; Brgles M; Steinberger S; Marchetti-Deschmann M; Halassy B
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33327454
[TBL] [Abstract][Full Text] [Related]
34. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
Szenczi A; Kardos J; Medgyesi GA; Závodszky P
Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
[TBL] [Abstract][Full Text] [Related]
35. Improved purification and yield of the Egyptian snake Cerastes cerastes antitoxin by the use of caprylic acid.
Seddik SS; Malak GA; Helmy MH
J Nat Toxins; 2002 Dec; 11(4):323-8. PubMed ID: 12503875
[TBL] [Abstract][Full Text] [Related]
36. Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows.
Estrada R; Herrera M; Segura A; Araya J; Boschini C; Gutiérrez JM; León G
Biologicals; 2010 Nov; 38(6):664-9. PubMed ID: 20833066
[TBL] [Abstract][Full Text] [Related]
37. Thermal stability of human immunoglobulins with sorbitol. A critical evaluation.
González M; Murature DA; Fidelio GD
Vox Sang; 1995; 68(1):1-4. PubMed ID: 7725666
[TBL] [Abstract][Full Text] [Related]
38. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
[TBL] [Abstract][Full Text] [Related]
39. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G.
Maury M; Murphy K; Kumar S; Mauerer A; Lee G
Eur J Pharm Biopharm; 2005 Feb; 59(2):251-61. PubMed ID: 15661497
[TBL] [Abstract][Full Text] [Related]
40. Liquid high concentration IgG1 antibody formulations by precipitation.
Matheus S; Friess W; Schwartz D; Mahler HC
J Pharm Sci; 2009 Sep; 98(9):3043-57. PubMed ID: 18823016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
